• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

作者信息

Messina F, Piaserico S

机构信息

Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e254-e255. doi: 10.1111/jdv.16468. Epub 2020 Jun 10.

DOI:10.1111/jdv.16468
PMID:32294258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7262156/
Abstract
摘要

相似文献

1
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.一名接受白细胞介素-23抑制剂治疗的银屑病患者感染了新型冠状病毒。
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e254-e255. doi: 10.1111/jdv.16468. Epub 2020 Jun 10.
2
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
3
Urticarial eruption in COVID-19 infection.新型冠状病毒肺炎感染中的荨麻疹样皮疹
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e244-e245. doi: 10.1111/jdv.16472.
4
The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.接受白细胞介素23通路抑制生物制剂治疗的银屑病患者发生呼吸道感染的风险：COVID-19大流行期间与决策相关的关键试验的荟萃估计。
J Am Acad Dermatol. 2020 Nov;83(5):1523-1526. doi: 10.1016/j.jaad.2020.06.1014. Epub 2020 Jul 2.
5
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
6
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.2019年冠状病毒病大流行对接受生物疗法治疗的慢性斑块状银屑病患者的影响：意大利北部的经验。
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
7
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.接受白细胞介素17通路抑制生物制剂治疗的银屑病患者发生呼吸道感染和症状的风险：对COVID-19大流行期间决策相关关键试验的荟萃估计。
J Am Acad Dermatol. 2020 Aug;83(2):677-679. doi: 10.1016/j.jaad.2020.05.035. Epub 2020 May 19.
8
Viral exanthem in COVID-19, a clinical enigma with biological significance.新冠病毒感染中的病毒疹，一个具有生物学意义的临床谜团。
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e251-e252. doi: 10.1111/jdv.16469. Epub 2020 Jun 1.
9
Clinical course of COVID-19 among immunocompromised children: a clinical case series.免疫功能低下儿童新型冠状病毒肺炎的临床病程：临床病例系列
BMJ Case Rep. 2020 Oct 31;13(10):e237804. doi: 10.1136/bcr-2020-237804.
10
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.意大利多中心研究：2020 年 4 月 10 日之前 SARS-CoV-2 感染儿童和青少年的初步数据。
Euro Surveill. 2020 May;25(18). doi: 10.2807/1560-7917.ES.2020.25.18.2000600.

引用本文的文献

1
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge.经受住风暴：年龄和生物制剂如何影响COVID-19细胞因子风暴
Pathogens. 2025 Apr 3;14(4):346. doi: 10.3390/pathogens14040346.
2
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.银屑病、银屑病关节炎和中轴型脊柱关节炎患者 COVID-19 结局不良的相关特征：COVID-19 PsoProtect 和全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2023 May;82(5):698-709. doi: 10.1136/ard-2022-223499. Epub 2023 Feb 14.
3
Clinical Features and Outcomes of Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease and Spondyloarthropathies.炎症性肠病和脊柱关节炎患者 2019 年冠状病毒病的临床特征和结局。
Turk J Gastroenterol. 2022 Sep;33(9):751-759. doi: 10.5152/tjg.2022.22181.
4
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review.单克隆抗体药物在COVID-19治疗中的应用：综述
Bionanoscience. 2022;12(4):1436-1454. doi: 10.1007/s12668-022-00997-9. Epub 2022 Jun 15.
5
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities.2019年冠状病毒病大流行期间中重度银屑病的治疗：经验教训与机遇
J Clin Med. 2022 Apr 26;11(9):2422. doi: 10.3390/jcm11092422.
6
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.新冠病毒的免疫特征：细胞因子风暴的深入原因及后果。
Int J Mol Sci. 2022 Apr 20;23(9):4545. doi: 10.3390/ijms23094545.
7
Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.生物制剂和小分子药物对炎症性肠病患者COVID-19相关住院率和死亡率的影响：一项系统评价和荟萃分析
JGH Open. 2022 Mar 20;6(4):241-250. doi: 10.1002/jgh3.12728. eCollection 2022 Apr.
8
Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic.银屑病红皮病型发作合并新型冠状病毒肺炎感染：两例报告及文献综述，重点关注银屑病与新型冠状病毒肺炎的相互影响以及疫情带来的特殊挑战
Clin Case Rep. 2022 Apr 20;10(4):e05722. doi: 10.1002/ccr3.5722. eCollection 2022 Apr.
9
Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination.新冠病毒辉瑞疫苗接种后银屑病急性加重
Proc (Bayl Univ Med Cent). 2021 Nov 15;35(2):199-201. doi: 10.1080/08998280.2021.2003681. eCollection 2022.
10
Biologics for Psoriasis During the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
Front Med (Lausanne). 2021 Dec 6;8:759568. doi: 10.3389/fmed.2021.759568. eCollection 2021.

本文引用的文献

1
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
2
[Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].[新型冠状病毒肺炎细胞因子风暴的机制及相关免疫治疗研究进展]
Zhonghua Shao Shang Za Zhi. 2020 Jun 20;36(6):471-475. doi: 10.3760/cma.j.cn501120-20200224-00088.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
4
Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?两名中东呼吸综合征冠状病毒（MERS-CoV）感染患者的不同免疫反应：我们能否从实验室走向临床？
PLoS One. 2014 Feb 14;9(2):e88716. doi: 10.1371/journal.pone.0088716. eCollection 2014.
5
Critical role of IL-17RA in immunopathology of influenza infection.白细胞介素-17受体A在流感感染免疫病理学中的关键作用。
J Immunol. 2009 Oct 15;183(8):5301-10. doi: 10.4049/jimmunol.0900995. Epub 2009 Sep 25.